Issue Areas

High-Value Therapies for Patients

Prescription drug prices continue to rise, threatening to make vital therapies unaffordable for many patients.

Learn more

As prescription drug costs continue to skyrocket, we must continue to advance the the conversation on how to define and assess drug value and lift up existing and emerging policy opportunities that encourage a value-based approach to drug pricing.

Featured content
Publications from PORTAL
Pile Of 20 Dollar Bills And Medicine Containers On White Background
How pharmaceutical marketing affects decisions about patient care
A Man Handing A Prescription To A Pharmacists
Restoring Provider Confidence In FDA-Approved Drugs
A Pharmacist Fulfilling A Prescription
Evolving nature of evidence required by FDA to approve new drugs
Kaiser Permanente Institute For Health Policy
When the best prescription is deprescribing
Prescription
Determining drug value: Let’s start with the evidence
It’s time to change drug companies’ harmful marketing practices
High Cost Of Prescription Drugs: Concept Prescription Bottles With Gavel
A deeper dive: Recommendations for strengthening the FDA’s REMS program to protect patients
Reflections on high drug pricing in America: Where we are and where we’re headed
Kaiser Permanente Institute For Health Policy Staff
A provider and payor’s perspective on drug pricing
Events
Pills
Building Racial Equity into the Drug Development System: Clinical Trials, Access, and Affordability
Pills
Building Racial Equity into the Drug Development System
Kaiser Permananete Institute For Total Health Forums
Addressing High Drug Pricing